Literature DB >> 1734861

Purification and characterization of a calpain activator from human platelets.

E Shiba1, H Ariyoshi, Y Yano, T Kawasaki, M Sakon, J Kambayashi, T Mori.   

Abstract

A calpain (Ca(2+)-activated neutral protease) activator was purified from human platelets by ammonium sulfate fractionation, gel-filtration, ion-exchange chromatography, followed by heat-treatment. The purified calpain activator with a Mr of 47.5 kDa was a heat-stable protein as demonstrated in other cells. The calpain activator did not change the Ca2+ sensitivity of calpain but activated calpain activity about 2-fold. This calpain activator may play an important role in the activation of the protease system leading to the Ca(2+)-mediated physiological process of platelets.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734861     DOI: 10.1016/0006-291x(92)91754-e

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

Authors:  J L Connolly; S E Rodgers; P Clarke; D W Ballard; L D Kerr; K L Tyler; T S Dermody
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

3.  The tra-3 sex determination gene of Caenorhabditis elegans encodes a member of the calpain regulatory protease family.

Authors:  T M Barnes; J Hodgkin
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

4.  Site-directed activation of calpain is promoted by a membrane-associated natural activator protein.

Authors:  F Salamino; R De Tullio; P Mengotti; P L Viotti; E Melloni; S Pontremoli
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

5.  Reovirus-induced apoptosis is preceded by increased cellular calpain activity and is blocked by calpain inhibitors.

Authors:  R L Debiasi; M K Squier; B Pike; M Wynes; T S Dermody; J J Cohen; K L Tyler
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.